Maryam Pourabdollah

Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification.

Hong Chang, A. Schimmer, E. Atenafu, 2017, Leukemia research.

EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies

Hong Chang, N. Rastgoo, Rosemarie Tremblay-Lemay, 2018, Biomarker Research.

Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma.

D. Reece, Hong Chang, E. Atenafu, 2018, Haematologica.

Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS

D. Reece, Hong Chang, J. Abdi, 2018, Leukemia.